Thanh bên bài viết

PDF (English)
Đã xuất bản: 2025-05-30
Số lượt xem tóm tắt: 19
Số lượt xem PDF (English): 17
DOI: https://doi.org/10.52852/tcncyh.v190i5E16.3508
Số xuất bản
Tập 190 Số 5E16 (2025)
Chuyên mục
Các bài báo
Cách trích dẫn
Cha, N. T. ., Ha, H. P. ., Thanh, N. T. ., Hung, B. T. ., Van Anh, P. T. ., Ha, N. T. T. ., Quang, T. V. ., & Hang, D. T. T. . (2025). In vivo assessment of acute and subchronic toxicity of Nanochitin in experimental animals. Tạp Chí Nghiên cứu Y học, 190(5E16), 137-144. https://doi.org/10.52852/tcncyh.v190i5E16.3508

In vivo assessment of acute and subchronic toxicity of Nanochitin in experimental animals

Nguyen Thi Cha, Ho Phu Ha, Nguyen Tien Thanh, Bui Tien Hung, Pham Thi Van Anh, Nguyen Thi Thanh Ha, Trinh Vinh Quang, Dinh Thi Thu Hang

Nội dung chính của bài viết

Tóm tắt

This study aimed to evaluate the safety of Nanochitin through oral administration in experimental animals. The acute toxicity was determined in mice at ascending doses and the subchronic toxicity was evaluated in rats with oral doses of 15.6 mg/kg b.w/day and 46.8 mg/kg b.w/day for 30 days. As a result, in the course of the acute toxicity test, Nanochitin at the highest dose of 750 mg/kg did not express acute toxicity in mice. Along with the subchronic toxicity test, Nanochitin had no deleterious effect on hematological parameters, hepato-renal functions, macroscopic and microscopic images of the livers and kidneys of rats. In conclusion, Nanochitin does not appear to produce acute and subchronic toxicities in experimental animals.

Chi tiết bài viết

Từ khóa

Nanochitin, acute toxicity, subchronic toxicity, experimental animals

Tài liệu tham khảo

1. Guite NT. International Protocol and Indigenous Knowledge on Medicine and Health Care: An overview. The Asian Man. 2010;1(4):01 - 12.
2. World Health Organization, Global report on traditional and complementary medicine. 2019.
3. Venkatasubbu GD, Ramasamy S, Gaddam PR, et al. Acute and subchronic toxicity analysis of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. International Journal of Nanomedicine. 2015;10:137-148.
4. De Jong WH, Carraway JW, Geertsma RE. In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. Biocompatibility and Performance of Medical Devices. 2012;120-158.
5. World Health Organization. Guidelines for Assessing Quality of Herbal Medicines With Reference to Contaminants and Residues, Geneva. 2007.
6. Denny KH, Stewart CW. Chapter 6 - Acute, Subacute, Subchronic, and Chronic General Toxicity Testing for Preclinical Drug Development. In: Faqi AS, eds. A Comprehensive Guide to Toxicology in Nonclinical Drug Development (Third Edition), Academic Press; 2024; Pages 149-171, ISBN 9780323857048.
7. World Health Organization. Working group on the safety and efficacy of herbal medicine. Report of regional office for the western pacific of the World Health Organization. 2000.
8. National Research Council. Toxicity testing for assessing environmental agents. Interim Report. Washington, DC, USA: National Academies Press. 2006.
9. Mostert V, Heimann KG, Doughty K. Examination of Acute and Repeated-Dose Toxicity. In: Reichl, FX., Schwenk, M. (eds). Regulatory Toxicology. Springer, Cham; 2021.